Omnipaque 350 Interactions
There are 324 drugs known to interact with Omnipaque 350 (iohexol), along with 2 disease interactions. Of the total drug interactions, 263 are major, and 61 are moderate.
- View all 324 medications that may interact with Omnipaque 350
- View Omnipaque 350 disease interactions (2)
Most frequently checked interactions
View interaction reports for Omnipaque 350 (iohexol) and the medicines listed below.
- 4 Way Saline (sodium chloride nasal)
- amlodipine
- amoxicillin
- Augmentin (amoxicillin / clavulanate)
- Benadryl (diphenhydramine)
- Claritin (loratadine)
- Coumadin (warfarin)
- doxycycline
- Eliquis (apixaban)
- erythromycin
- famotidine
- finasteride
- gabapentin
- gentamicin
- ibuprofen
- iodinated i 131 albumin
- Lactated Ringers Injection (lvp solution)
- losartan
- Melatonin Time Release (melatonin)
- metformin
- Microgestin 1.5 / 30 (ethinyl estradiol / norethindrone)
- MiraLAX (polyethylene glycol 3350)
- omega-3 polyunsaturated fatty acids
- omeprazole
- Paracetamol (acetaminophen)
- Paxlovid (nirmatrelvir / ritonavir)
- Tylenol with Codeine #3 (acetaminophen / codeine)
- Ultram (tramadol)
- Vitamin B12 (cyanocobalamin)
- Vitamin D3 (cholecalciferol)
Omnipaque 350 disease interactions
There are 2 disease interactions with Omnipaque 350 (iohexol) which include:
Report options
QR code containing a link to this page
More about Omnipaque 350 (iohexol)
- Omnipaque 350 consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (4)
- Latest FDA alerts (2)
- Side effects
- Dosage information
- During pregnancy
- Drug class: non-ionic iodinated contrast media
- Breastfeeding
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
